Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.
Abstract Animal and human studies indicate that cannabidiol (CBD), a major constituent of cannabis, has anxiolytic properties. However, no study to date has investigated the effects of this compound on human pathological anxiety and its underlying brain mechanisms. The aim of
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
ABSTRACT Generalized Social Anxiety Disorder (SAD) is one of the most common anxiety conditions with impairment in social life. Cannabidiol (CBD), one major non-psychotomimetic compound of the cannabis sativa plant, has shown anxiolytic effects both in humans and in animals. This
ABSTRACT While there’s currently a lack of large-scale clinical trials testing the use of CBD oil in the treatment of anxiety, a small study published in Neuropsychopharmacology in 2011 determined that CBD may help alleviate social anxiety. For this study, 24 people
ABSTRACT Panic disorder (PD) is a disabling psychiatry condition that affects approximately 5% of the worldwide population. Currently, long-term selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for PD; however, the common side-effect profiles and drug interactions may provoke patients